Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Review

Toll-like receptor downstream signaling

Taro Kawai1 and Shizuo Akira1,2 email

1ERATO, Japan Science and Technology Agency, Osaka, Japan

2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

author email corresponding author email

Arthritis Res Ther 2005, 7:12-19doi:10.1186/ar1469

Published: 30 November 2004

Abstract

The family of Toll-like receptors (TLRs) senses conserved structures found in a broad range of pathogens, causing innate immune responses that include the production of inflammatory cytokines, chemokines and interferons. The signal transduction is initiated from the Toll/interleukin-1 receptor (TIR) domain of TLRs after pathogen recognition. Almost all TLRs use a TIR-containing adapter MyD88 to activate a common signaling pathway that results in the activation of NF-κB to express cytokine genes relevant to inflammation. Recently, three further TIR-containing adapters have been identified and shown to selectively interact with several TLRs. In particular, activation of the TRIF-dependent pathway confers antiviral responses by inducing anti-viral genes including that encoding interferon-β. Taken together, these results indicate that the interaction between individual TLRs and the different combinations of adapters directs appropriate responses against distinct pathogens.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.